![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Gedeon Richter Plc Budapest Hu, based in Hungary, is a pharmaceutical company.
One of their significant offerings is Enalapril maleate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2001-408 - Rev 03
This Chemical Type CEP, issued on November 25, 2010, remains in force until July 31, 2013, ensuring its reliability within the pharmaceutical industry.
Substance Number 1420 associated with this CEP further emphasizes